TY  - JOUR
T1  - Breast Cancer Associated Conventional and Advanced Therapies 
A1  - Kirti Amresh Gautam
A1  - Nimisha Singh
A1  - Priyanka Tyagi
A1  - Gunja Jha
A1  - Anushka Raman
JF  - International Journal of Pharmaceutical And Phytopharmacological Research
JO  - Int J Pharm Phytopharmacol Res
SN  - 2250-1029
Y1  - 2023
VL  - 13
IS  - 3
DO  - 10.51847/nQUUw5hfzg
SP  - 22
EP  - 37
N2  - Globally, breast cancer (BC) is the second most lethal cancer that affects women and in rare cases, men as well. More than 90% of breast cancer-associated deaths are caused due to late identification that leads to metastasis. Biopsy report along with imaging work-up (MRI- and CT-scans) predicts the diagnosis that ultimately uses for the establishment of treatment options. Currently, breast cancer treatment has broad and diverse approaches, it comprises conventional treatments which include oncoplastic breast surgery, radiation therapy, and adjuvant chemotherapy while advanced treatments include systemic therapy approaches including targeted therapy, hormone therapy, and immunotherapy. Advanced treatments aim to attack cancer cells specifically, reduce side effects and improve treatment outcomes for patients. The therapies can be further diverged and depend on taking the grounds of molecular subtypes of BC, patient health, and personal preferences along with regular screening. In this review, we have highlighted different therapeutic approaches including targeted therapy, chemotherapy, and hormonal therapy employed based on molecular subtypes of BC. 
UR  - https://eijppr.com/article/breast-cancer-associated-conventional-and-advanced-therapiesnbsp-fi9zwcjw1nrtipi
ER  -